← Open Payments lookup

GINGER VEGA: Open Payments

NPI 1851074934 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$527 in 22 payments from 7 companies in 2025. Trend: 2023 $465 · 2024 $897 · 2025 $527

Food & beverage: $527
CompanyPaymentsAmount
ABBVIE INC.11$211
Sage Therapeutics, LLC1$120
Janssen Pharmaceuticals, Inc3$61
Alkermes, Inc.2$40
Teva Pharmaceuticals USA, Inc.2$38
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$34
Otsuka America Pharmaceutical, Inc.1$23

Products named: VRAYLAR, INVEGA SUSTENNA, ARISTADA, AUSTEDO XR, CAPLYTA, ABILIFY MAINTENA.

Industry payments across LA — which companies pay providers there.